Renflexis
PHONETIC PRONUNCIATION: Renflexis
Description
Renflexis is an FDA-approved biosimilar drug used to treat autoimmune diseases such as Crohn's disease, rheumatoid arthritis, psoriasis, and ulcerative colitis. It contains the same active ingredient as the drug infliximab and works by suppressing the immune system to reduce inflammation. Uses: Renflexis is prescribed to relieve symptoms of autoimmune diseases such as Crohn's disease, rheumatoid arthritis, psoriasis and ulcerative colitis. It is also used in combination with other medications to treat ankylosing spondylitis, a type of arthritis that affects the spine. Dosage: The dosage of Renflexis is prescribed by a healthcare provider based on the individual patient's needs. It is administered intravenously over the course of approximately two hours. The typical dose is 5-10 milligrams per kilogram of body weight. Follow your healthcare provider's instructions on dosing and schedule of administration. Demographic: Renflexis is approved for use in adults with autoimmune diseases. Its safety and effectiveness have not been established in pediatric patients. Side Effects: The use of Renflexis may cause side effects which may vary in severity depending on the patient. Common side effects include headache, fatigue, and rash. More serious side effects may include difficulty breathing and an increased risk of infections. Patients should speak with their healthcare provider if they experience any side effects. Interactions: It is important to tell your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, as they may interact with the use of Renflexis. This medication may also cause increased susceptibility to infections. Patients should avoid contact with individuals who have infectious diseases while using Renflexis. Generic Options: Renflexis is a biosimilar drug of infliximab and does not currently have any generic options. In conclusion, Renflexis is a medication approved for use in adults with autoimmune diseases. It is dosed intravenously and works by suppressing the immune system to reduce inflammation. Its use may cause side effects, and patients should speak with their healthcare provider if they experience any adverse reactions. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. As a biosimilar drug, Renflexis currently does not have any generic options available.
Faq for Renflexis
Renflexis is a medication used to treat certain immune-mediated inflammatory diseases such as Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
Renflexis is a biosimilar to infliximab, which means it is highly similar to the reference biologic drug. It works by blocking the activity of a protein called tumor necrosis factor-alpha (TNF-alpha), which is involved in causing inflammation in the body.
The common side effects of Renflexis may include headache, nausea, stomach pain, diarrhea, respiratory tract infections, sinus infections, and reactions at the injection site. It is important to discuss any concerning side effects with your doctor.
Renflexis is typically administered intravenously (IV) by a healthcare professional. The dose and frequency depend on the specific condition being treated, and it is important to follow the dosage instructions provided by your doctor.
The use of Renflexis during pregnancy should be discussed with a healthcare provider. It is generally recommended to avoid Renflexis during pregnancy, unless the potential benefits outweigh the risks.
Renflexis is approved for use in pediatric patients aged 6 years and older with moderately to severely active Crohn's disease. The use in other pediatric populations may vary and should be discussed with a healthcare provider.
The time for Renflexis to start working can vary depending on the condition being treated, individual response, and other factors. Some patients may start experiencing improvement within a few weeks, while others may take longer. It is important to follow the treatment plan recommended by your doctor.
Renflexis may be covered by insurance depending on your specific insurance plan and coverage. It is advisable to check with your insurance provider or pharmacist to determine coverage and any necessary steps for approval or prior authorization.
It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and herbal supplements. Certain medications, such as live vaccines, may interact with Renflexis, so it is important to discuss potential interactions with your doctor.